ZEPHYR AI

zephyr-ai-logo

Zephyr AI is a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery and precision medicine. Zephyr AI collaborates with top health systems, health insurance plans, and biotechnology innovators to enhance Quality, Outcomes, and Costs.

#SimilarOrganizations #People #Financial #Event #Website #More

ZEPHYR AI

Social Links:

Industry:
Artificial Intelligence (AI) Biotechnology Medical

Founded:
2020-01-01

Address:
Fairfax Station, Virginia, United States

Country:
United States

Website Url:
http://www.zephyrai.bio

Total Employee:
11+

Status:
Active

Total Funding:
129.5 M USD

Technology used in webpage:
Domain Not Resolving HSTS ReCAPTCHA ReCAPTCHA V2 Amazon CloudFront Amazon Cognito Cloudflare Radar AWS Cloudfront Taipei TW Edge Cloudflare Radar Top 500k AWS Cloudfront Manila Edge


Similar Organizations

maplight-therapeutics-logo

MapLight Therapeutics

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

arctic-therapeutics-logo

Arctic Therapeutics

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.

coriell-life-sciences-logo

Coriell Life Sciences

Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.

ocean-biomedical-logo

Ocean Biomedical

Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.

om1-logo

OM1

OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.

proscia-logo

Proscia

Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

vivodyne-logo

Vivodyne

Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.

Current Employees Featured

david-morgan_image

David Morgan
David Morgan Strategic Advisor @ Zephyr AI
Strategic Advisor
2024-03-01

david-morgan_image

David Morgan
David Morgan Chief Executive Officer @ Zephyr AI
Chief Executive Officer
2022-01-01

jeff-sherman_image

Jeff Sherman
Jeff Sherman Co-Founder, Interim CEO, and CTO @ Zephyr AI
Co-Founder, Interim CEO, and CTO
2020-09-01

andrey-chursov_image

Andrey Chursov
Andrey Chursov EVP of Science and Technology @ Zephyr AI
EVP of Science and Technology
2022-01-01

rachael-brake_image

Rachael Brake
Rachael Brake Chief Scientific Officer @ Zephyr AI
Chief Scientific Officer
2024-02-01

eric-lindquist_image

Eric Lindquist
Eric Lindquist Chief Business Officer @ Zephyr AI
Chief Business Officer
2023-06-01

justin-stebbing_image

Justin Stebbing
Justin Stebbing Chair @ Zephyr AI
Chair

grant-l-verstandig_image

Grant L. Verstandig
Grant L. Verstandig Co-Founder and Executive Chairman @ Zephyr AI
Co-Founder and Executive Chairman
2021-04-01

Founder


grant-l-verstandig_image

Grant L. Verstandig

jeff-sherman_image

Jeff Sherman

Investors List

eli-lilly-company-foundation_image

Eli Lilly & Company Foundation

Eli Lilly & Company Foundation investment in Series A - Zephyr AI

revolution-growth-bac6_image

Revolution Growth

Revolution Growth investment in Series A - Zephyr AI

jeff-skoll-3_image

Jeff Skoll

Jeff Skoll investment in Series A - Zephyr AI

epiq-capital-group_image

EPIQ Capital Group

EPIQ Capital Group investment in Series A - Zephyr AI

allen-chao_image

Allen Chao

Allen Chao investment in Seed Round - Zephyr AI

boxgroup_image

BoxGroup

BoxGroup investment in Seed Round - Zephyr AI

lerner-investments_image

Lerner Enterprises

Lerner Enterprises investment in Seed Round - Zephyr AI

liquid2-ventures_image

Liquid 2 Ventures

Liquid 2 Ventures investment in Seed Round - Zephyr AI

ame-cloud-ventures_image

AME Cloud Ventures

AME Cloud Ventures investment in Seed Round - Zephyr AI

medstar-health_image

MedStar Health

MedStar Health investment in Seed Round - Zephyr AI

Official Site Inspections

http://www.zephyrai.bio Semrush global rank: 6.25 M Semrush visits lastest month: 1.07 K

  • Host name: ec2-52-4-138-112.compute-1.amazonaws.com
  • IP address: 52.4.138.112
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Zephyr AI"

Zephyr AI

At Zephyr we're building a team of highly motivated experts who: Thrive in cross disciplinary environments; Revel in the continuous cycle of learning and teaching, fostering a culture of โ€ฆSee details»

Zephyr's Unique Federated Data Powers Our Models - zephyrai.bio

Zephyr possesses one of the largest clinicogenomic datasets in the world, including over 68 million longitudinal patient records updated at regular intervals. Our foundational AI models โ€ฆSee details»

Zephyr AI - Crunchbase Company Profile & Funding

Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.See details»

From data ingestion to production in less than 30 days: โ€ฆ

Zephyr AI combines data science with engineering to help health providers and plans transform prevention, care delivery, and treatment. The Zephyr platform ingests real-world data, then uses transparent artificial intelligence (AI) and โ€ฆSee details»

Zephyr AI - LinkedIn

Zephyr AI uses large complex data and proprietary algorithms to discover new insights and opportunities for Personalized/Precision Medicine, Drug Discovery, Drug Rescue, and Clinical Decision Support.See details»

Zephyr AI Raises $18.5 Million in Seed Funding Led by โ€ฆ

Mar 30, 2022 As an organization deeply committed to being at the forefront of successful initiatives in medical research, we are delighted to be participating.โ€ ... [email protected]. Recent News Team Cincoro Unleashed: All- Star Lineup โ€ฆSee details»

Red Cell Forms Zephyr AI to Revolutionize Drug โ€ฆ

Nov 22, 2021 To stay up-to-date: visit us at www.zephyrai.bio and follow us on LinkedIn. Contacts Media Contact: Charles V. Zehren Rubenstein 212-843-8590 [email protected]See details»

Zephyr AI Raises $111 Million in Series A Financing

MCLEAN, Va., March 13, 2024--Zephyr AI, Inc. ("Zephyr AI"), a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) solutions to โ€ฆSee details»

Experienced Biotech Executive and Deal Maker Joins Zephyr AI as โ€ฆ

Jun 5, 2023 Visit us at www.zephyrai.bio and follow us on Twitter, Instagram, and LinkedIn. Contacts Katie Griff Head of Marketing, Zephyr AI [email protected] Liz Boten Evoke Canale โ€ฆSee details»

Zephyr AI

AI-enabled composite biomarkers for enhanced clinical development. Work at Zephyr AI. We are a multidisciplinary team of world-class software engineers, scientists, and entrepreneurs โ€ฆSee details»

Zephyr AI Raises $18.5 Million in Seed Funding Led by Lerner and โ€ฆ

Mar 30, 2022 As an organization deeply committed to being at the forefront of successful initiatives in medical research, we are delighted to be participating.โ€ ... Visit us at zephyrai.bio โ€ฆSee details»

Zephyr AI - Company info. interviews, news - BiopharmaTrend

Https://www.zephyrai.bio. Founded 2021. Publications 2. Zephyr AI is a high-growth healthcare technology company committed to radically rebuilding drug discovery and precision medicine โ€ฆSee details»

Zephyr AI - Craft

Zephyr AI has 5 employees at their 1 location and $18.5 m in total funding,. See insights on Zephyr AI including office locations, competitors, revenue, financials, executives, subsidiaries โ€ฆSee details»

Zephyr AI Raises $111 Million in Series A Financing

Mar 13, 2024 MCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, Inc. (โ€œZephyr AIโ€), a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) โ€ฆSee details»

Zephyr AI taps biotech executive Rachael Blake as CSO - Fierce โ€ฆ

Apr 2, 2024 Three-year-old AI precision medicine company Zephyr AI brought on board a scientist and executive with deep biotech and pharma experience to lead its strategic and โ€ฆSee details»

Zephyr AI Announces the Appointment of John Applegate as its CFO

May 16, 2024 Applegateโ€™s appointment comes as Zephyr AI prepares to present a scientific poster (Abstract # 5583/454: Evaluation of novel signature for PARP inhibitor sensitivity โ€ฆSee details»

Zephyr AI noncon deck September-25-24

The Value Proposition of Patient Selection Is Unambiguous $23.0 $7.1 $6.3 $0.7 $7.0 $4.7 $3.2 $3.5 $3.1 $2.5 $5.3 Potential R&D Cost Savings with CDx by Disease CDx Can Cut Clinical โ€ฆSee details»

Zephyr AI Presents the Development of a Novel AI-Enabled โ€ฆ

MCLEAN, Va., June 03, 2024--Zephyr AI, a high-growth healthcare technology company committed to developing AI-Enabled Composite Biomarkers to expand the horizon of precision โ€ฆSee details»

Zephyr AI

AI-enabled composite biomarkers for enhanced clinical developmentSee details»

linkstock.net © 2022. All rights reserved